Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 19/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 16/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 10/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 10/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6181512 | 0.82 | F2 (0.71) | F2 | |
| SCHEMBL2999971 | 0.81 | F2 (0.59) | F2HDAC6HDAC1HDAC4HDAC3 | |
| SCHEMBL2202349 | 0.81 | HDAC6 (0.59) | HDAC6HDAC1HDAC4HDAC3 | |
| Trifluoroacetic Acid SCHEMBL5656425 | 0.76 | F2 (0.77) | F2HDAC6 | |
| SCHEMBL7369616 | 0.75 | DAO (0.68) | F2HDAC6HDAC1HDAC4HDAC3 | |
| SCHEMBL2227006 | 0.75 | CES2 (0.59) | HDAC6HDAC1HDAC4HDAC3 | |
| SCHEMBL12310794 | 0.75 | HDAC6 (0.59) | HDAC6HDAC1HDAC4HDAC3HDAC7 | |
| SCHEMBL12426785 | 0.75 | HDAC6 (0.68) | HDAC6HDAC1HDAC4HDAC3CYP2C9 | |
| SCHEMBL13154032 | 0.75 | HDAC6 (0.57) | HDAC6HDAC1HDAC4HDAC3CYP2C9 | |
| SCHEMBL19071177 | 0.74 | F2 (0.47) | F2HDAC6HDAC1HDAC4HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1926721-B1 | THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | MSD ITALIA SRL (IT) | 2016-05-04 | — | — | EP | disclosed |
| WO-2013181487-A3 | METHOD OF TREATING | STIEFEL LABORATORIES, INC. (US) | 2014-01-30 | — | — | WO | disclosed |
| WO-2013181487-A2 | METHOD OF TREATING | STIEFEL LABORATORIES, INC. (US) | 2013-12-05 | — | — | WO | disclosed |
| US-7977374-B2 | Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2011-07-12 | — | — | US | disclosed |
| US-20090156591-A1 | Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors | MSD ITALIA S.R.L. (IT) | 2009-06-18 | — | — | US | disclosed |
| EP-1926721-A2 | THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007029035-A2 | THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156591-A1 | Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors | HDAC1, HDAC2, HDAC11 | F2 4197/4885HDAC6 6/4885HDAC1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.